Coronavirus Disease 2019 (COVID-19)
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
FDA is working with U.S. government partners, including CDC, and international partners to address the pandemic.
The FDA’s multipronged response to monkeypox includes efforts in the areas of diagnostics, vaccines and therapeutics.
The FDA continues to work around the clock with our government partners and industry to ensure there's adequate infant formula available wherever and whenever parents and caregivers need it.
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Nov 29
Food & Beverages
Nov 28
Drugs
Nov 23
Food & Beverages
CMAP will leverage Artificial Intelligence and Machine Learning technologies to enhance cyber detection and response capabilities.
FDA is working with infant formula manufacturers to maximize production and taking steps to assure the public that infant formula is and will remain safe.
Increasing the availability of safe and effective medicines for children is a key priority for the U.S. Food and Drug Administration.
Nov 30
Animal & Veterinary
Nov 29
Food & Beverages
Nov 29
Food & Beverages